BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 9099940)

  • 1. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells.
    Thornton BP; Vetvicka V; Ross GD
    Clin Exp Immunol; 1996 Jun; 104(3):531-7. PubMed ID: 9099940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes.
    Thornton BP; Vĕtvicka V; Ross GD
    J Immunol; 1994 Feb; 152(4):1727-37. PubMed ID: 8120381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans.
    Halkjær L; Troldborg A; Pedersen H; Jensen L; Hansen AG; Hansen TK; Bjerre M; Østergaard JA; Thiel S
    Front Immunol; 2020; 11():774. PubMed ID: 32431705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stimulation of T cells with anti-CD2 monoclonal antibodies facilitates the induction of polyclonal B-cell responses but does not enhance the activation of antigen-specific B cells.
    Trifiletti R; Hyman B; LaVia M; Knapp W; Virella G
    Scand J Immunol; 1990 Jan; 31(1):25-31. PubMed ID: 1689073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
    Iida K; Mitomo K; Fujita T; Tamura N
    J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced binding of immune complexes processed by erythrocyte CR1 (CD 35) receptors to purified CR2 (CD 21) receptors from tonsillar mononuclear cells.
    Rask R; Rasmussen JM; Jepsen HH; Svehag SE
    APMIS; 1989 Apr; 97(4):374-80. PubMed ID: 2524204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
    Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
    J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21).
    Hess MW; Schwendinger MG; Eskelinen EL; Pfaller K; Pavelka M; Dierich MP; Prodinger WM
    Blood; 2000 Apr; 95(8):2617-23. PubMed ID: 10753842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice.
    Whipple EC; Shanahan RS; Ditto AH; Taylor RP; Lindorfer MA
    J Immunol; 2004 Aug; 173(4):2297-306. PubMed ID: 15294942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
    Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
    J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
    Guthridge JM; Young K; Gipson MG; Sarrias MR; Szakonyi G; Chen XS; Malaspina A; Donoghue E; James JA; Lambris JD; Moir SA; Perkins SJ; Holers VM
    J Immunol; 2001 Nov; 167(10):5758-66. PubMed ID: 11698449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.
    Diefenbach RJ; Isenman DE
    J Immunol; 1995 Mar; 154(5):2303-20. PubMed ID: 7868901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation.
    Volkman DJ; Lane HC; Fauci AS
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2528-31. PubMed ID: 6972539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors.
    Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E
    J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD21 augments antigen presentation in immune individuals.
    Boackle SA; Holers VM; Karp DR
    Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous red blood cells potentiate antibody synthesis by unfractionated human mononuclear cell cultures.
    Rugeles MT; La Via M; Goust JM; Kilpatrick JM; Hyman B; Virella G
    Scand J Immunol; 1987 Aug; 26(2):119-27. PubMed ID: 3114872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human/mouse radiation chimera are capable of mounting a human primary humoral response.
    Marcus H; David M; Canaan A; Kulova L; Lubin I; Segall H; Denes L; Erlich P; Galun E; Gan J
    Blood; 1995 Jul; 86(1):398-406. PubMed ID: 7795248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
    Baatrup G; Svehag SE; Jensenius JC
    Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.